Dermata Therapeutics Inc. (DRMA)
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Medi Lifestyle - Announcement
OUE Healthcare Limited - Announcement
Changes To The Composition Of The Board Of Directors And The Nominating And Remuneration Committee
Change - Announcement Of Cessation :: Resignation Of Non-Independent And Non-Executive Director
How Is The iPhone 16 Pro Max Compared To The iPhone 17 Pro Max?
Is The iPhone 12 Still Good In 2026?